Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section 1, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Contract No. N01-AI-30052 Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 0000 Xxxxxxxx, Room 6B05 0000 XXXXXXXXX XXXX XXX 0000 XXXXXXXX XX 00000-0000 These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Samples: Pharmathene, Inc
Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section 1I, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Contract No. N01-AI-30052 Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 0000 Xxxxxxxx6100 Building, Room 6B05 0000 XXXXXXXXX XXXX XXX 0000 XXX-0000 XXXXXXXX XX 00000-0000 These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Samples: Acambis PLC
Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section 1I, the cognizant Contracting Officer representative representative' responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Contract No. N01-AI-30052 Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 0000 Xxxxxxxx, Room 6B05 0000 XXXXXXXXX XXXX XXX 0000 XXX-0000 XXXXXXXX XX 00000-0000 These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Samples: Paradigm Genetics Inc
Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section 1I, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Contract No. Back to Contents N01-AI-30052 AI-30030 Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 0000 Xxxxxxxx, Room 6B05 0000 XXXXXXXXX XXXX XXX 0000 XXXXXXXX XX 00000-0000 These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section 1I, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Contract No. N01-AI-30052 Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 0000 Xxxxxxxx6100 Building, Room 6B05 0000 XXXXXXXXX XXXX XXX 0000 XXX-0000 XXXXXXXX XX 00000-0000 These rates are hereby incorporated without further action of the Contracting Officer.. Contract No. HHSN261200655000C
Appears in 1 contract
Samples: Seracare Life Sciences Inc
Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(27(d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section 1I, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Contract No. N01-AI-30052 Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 0000 Xxxxxxxx6100 Building, Room 6B05 0000 XXXXXXXXX XXXX XXX 0000 XXXXXXXX XX 00000XXX-0000 XXXXXXXX, MD 20892-0000 7540 These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Samples: Vaxgen Inc
Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1I) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section 1I, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: 12 Contract No. N01HHSN26620040071C ADB Contract No. NOI-AI-30052 AI-40071 Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 0000 6000 Xxxxxxxx, Room 6B05 0000 6000 XXXXXXXXX XXXX XXX 0000 XXXXXXXX XX 00000-0000 These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Samples: Acambis PLC
Indirect Cost Rates. In accordance with Federal Acquisition Regulation (FAR) (48 CFR Chapter 1) Clause 52.216-7 (d)(2), Allowable Cost and Payment incorporated by reference in this contract in Part II, Section 1I, the cognizant Contracting Officer representative responsible for negotiating provisional and/or final indirect cost rates is identified as follows: Contract No. N01-AI-30052 Director, Division of Financial Advisory Services Office of Acquisition Management and Policy National Institutes of Health 0000 Xxxxxxxx6100 Building, Room 6B05 [***] 0000 XXXXXXXXX XXXX XXX 0000 XXXXXXXX XX 00000XXX-[***] BETHESDA MD 20892-0000 7540 These rates are hereby incorporated without further action of the Contracting Officer.
Appears in 1 contract
Samples: Isis Pharmaceuticals Inc